| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.05▼ | 11.09▼ | 11.14▼ | 11.45▼ | 10.41▲ |
| MA10 | 11.05▼ | 11.17▼ | 11.29▼ | 11.23▼ | 9.53▲ |
| MA20 | 11.06▼ | 11.29▼ | 11.41▼ | 10.30▲ | 8.66▲ |
| MA50 | 11.24▼ | 11.49▼ | 11.41▼ | 9.11▲ | N/A |
| MA100 | 11.37▼ | 11.37▼ | 10.70▲ | 8.72▲ | N/A |
| MA200 | 11.51▼ | 10.59▲ | 9.79▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | -0.030▼ | -0.061▼ | 0.055▲ | 1.606▲ |
| RSI | 42.089▼ | 40.167▼ | 40.053▼ | 61.802▲ | 45.053▼ |
| STOCH | 44.822 | 32.556 | 34.747 | 76.457 | 78.841 |
| WILL %R | -82.609▼ | -75.439▼ | -75.862▼ | -31.970 | -15.158▲ |
| CCI | -39.164 | -66.811 | -109.321▼ | 27.723 | 131.919▲ |
|
Sunday, June 15, 2025 04:45 AM
Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab ...
|
|
Tuesday, June 10, 2025 08:59 AM
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which ...
|
|
Thursday, June 05, 2025 04:12 AM
The model used to summarize this release may make mistakes. See the full release here. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 10.94 | 11.16 | 10.835 | 11.045 | 133,970 |
| 13/06/25 | 11.20 | 11.69 | 11.10 | 11.36 | 221,700 |
| 12/06/25 | 11.63 | 12.10 | 11.24 | 11.56 | 305,800 |
| 11/06/25 | 11.80 | 12.068 | 11.318 | 11.68 | 645,000 |
| 10/06/25 | 11.365 | 11.64 | 11.14 | 11.59 | 232,910 |
| 09/06/25 | 11.52 | 11.695 | 11.175 | 11.29 | 272,840 |
| 06/06/25 | 10.83 | 11.52 | 10.83 | 11.27 | 207,200 |
| 05/06/25 | 10.85 | 11.0099 | 10.21 | 10.83 | 199,962 |
| 04/06/25 | 10.84 | 11.225 | 10.6392 | 10.86 | 210,922 |
| 03/06/25 | 10.96 | 11.065 | 10.10 | 10.84 | 386,097 |
|
|
||||
|
|
||||
|
|